Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403325
Status:
COMPLETED
Last Update Posted:
2008-11-02
First Post:
2006-11-22
Brief Title:
Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Sponsor:
Vitreous -Retina- Macula Consultants of New York
Organization:
Vitreous -Retina- Macula Consultants of New York
Organization Data
Organization:
Vitreous -Retina- Macula Consultants of New York
Class:
OTHER
Study ID:
FVF3850S
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vitreous -Retina- Macula Consultants of New York
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Richard Spaide MD Principal Investigator
Old Organization:
Vitreous Retina Macula Consultants of New York
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |